De Novo device
Teal Wand
Teal Health, Inc. · Device For Home Collection And Transport Of Vaginal Specimens By Lay Users For Use In An Approved Hpv Molecular Assay (SEP, Class II) · First FDA decision May 9, 2025, newest May 9, 2025Cervical cancer and HPV
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
1
Naming "Teal Wand"
MAUDE reports
0
Brand "Teal Wand", since 2015
PubMed studies
2
Mentioning "Teal Wand"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Teal Wand
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Teal WandNew device typeBreakthroughDe Novo
DEN240045 · Decided May 9, 2025 · 255 days after receipt
Device type: Device For Home Collection And Transport Of Vaginal Specimens By Lay Users For Use In An Approved Hpv Molecular Assay (SEP) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- MolDX: Molecular Assays for the Diagnosis of Cutaneous MelanomaLocal determinationIn effectL39389CGS Administrators, LLCUpdated Apr 6, 2026
- MolDX: Molecular Assays for the Diagnosis of Cutaneous MelanomaLocal determinationIn effectL39373Noridian Healthcare Solutions, LLCUpdated Jan 12, 2026
- MolDX: Molecular Assays for the Diagnosis of Cutaneous MelanomaLocal determinationIn effectL39479WPS Insurance CorporationUpdated Apr 22, 2025
- MolDX: Molecular Assays for the Diagnosis of Cutaneous MelanomaLocal determinationIn effectL39345Palmetto GBAUpdated Jun 16, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Teal Wand", any status and sponsor, newest update first.
- SELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer ScreeningPivotal-lookingActive, not recruiting
Teal Health, Inc.Not on our public-company list
NCT06120205 · 870 participants (planned) · Start Nov 20, 2023 · Primary completion Apr 5, 2024
Device: Teal Wand Self-Collection Device Group · For: Hpv; HPV 16 Infection; HPV Infection and 1 more
Sites: Birmingham, Alabama; San Francisco, California; Aurora, Colorado · 15 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Teal Wand", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code SEP
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Teal Wand"[tiab]. The summary above synthesizes these.
- Teal Wand - an at-home cervical cancer screening device.
Med Lett Drugs Ther · 2025
- Delivering HPV results via telehealth: Patient needs and engagement following an at-home self-collection study.
Swenson E, VonderHaar E, Ruiz J, et al. · Digit Health · 2026
Other devices of this type
Also filed under product code SEP.
- Onclarity Self-Collection KitBecton, Dickinson and Company · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.